Skip to search formSkip to main contentSkip to account menu

Bradykinin Receptor Antagonists

Known as: Receptor Blockers, Bradykinin, Bradykinin Antagonists, Antagonists, Bradykinin Receptor 
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
To cite this article: Maurer M, Bader M, Bas M, Bossi F, Cicardi M, Cugno M, Howarth P, Kaplan A, Kojda G, Leeb‐Lundberg F, L… 
Review
2007
Review
2007
  • J. Schouten
  • Current opinion in critical care
  • 2007
  • Corpus ID: 20678419
Purpose of reviewTranslating the efficacy of neuroprotective agents in experimental traumatic brain injury to clinical benefit… 
Highly Cited
2007
Highly Cited
2007
To explore the role of the kallikrein–kinin system in relation to ischemia/reperfusion injury in the kidney, we generated mice… 
Highly Cited
2000
Highly Cited
2000
Bradyzide is from a novel class of rodent‐selective non‐peptide B2 bradykinin antagonists (1‐(2‐Nitrophenyl)thiosemicarbazides… 
Highly Cited
1998
Highly Cited
1998
The mechanism of the enhanced vascular permeability and retention (EPR) effect seen in solid tumors was investigated with sarcoma… 
Highly Cited
1995
Highly Cited
1992
Highly Cited
1992
A systematic study on the dimerization of the bradykinin (BK) antagonist D-Arg0-Arg1-Pro2-Hyp3-Gly4-Phe5-Ser6-D-Phe 7-Leu8-Arg9… 
Highly Cited
1991
Highly Cited
1991
1 Three new bradykinin (BK) antagonists, d‐Arg0‐Hyp3‐Thi5‐d‐Tic7‐Oic8‐BK (compound I), d‐Arg0‐Hyp3‐d‐Tic7‐Oic8‐BK (compound II… 
Highly Cited
1988
Highly Cited
1988
Autoradiographic studies localize [3H]bradykinin receptor binding sites to the substantia gelatinosa, dorsal root, and a subset…